| 697898 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer |
2021-06-01 |
10.1136/jitc-2020-002036 |
Klopfenstein Quentin, Derangère Valentin, Arnould Laurent, Thibaudin Marion, Limagne Emeric, Ghiringhelli Francois, Truntzer Caroline, Ladoire Sylvain |
| 697897 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
2021-06-01 |
10.1136/jitc-2021-002523 |
Shi Wei, Qiu Qianqian, Feng Ziying, Tong Zhenzhen, Guo Weiwei, Zou Feng, Yue Na, Huang Wenlong, Qian Hai |
| 697896 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release |
2021-06-01 |
10.1136/jitc-2021-002488 |
Dang Kevin, Castello Giulia, Clarke Starlynn C, Li Yuping, Balasubramani Aarti, Boudreau Andrew, Davison Laura, Harris Katherine E, Pham Duy, Sankaran Preethi, Ugamraj Harshad S, Deng Rong, Kwek Serena, Starzinski Alec, Iyer Suhasini, van Schooten Wim, Schellenberger Ute, Sun Wenchao, Trinklein Nathan D, Buelow Roland, Buelow Ben, Fong Lawrence, Dalvi Pranjali |
| 697895 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time? |
2021-06-01 |
10.1136/jitc-2020-002248 |
Ahern Elizabeth, Solomon Ben J, Hui Rina, Pavlakis Nick, O'Byrne Ken, Hughes Brett G M |
| 697894 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma |
2021-06-01 |
10.1136/jitc-2020-002181 |
Simonds Erin F, Lu Edbert D, Badillo Oscar, Karimi Shokoufeh, Liu Eric V, Tamaki Whitney, Rancan Chiara, Downey Kira M, Stultz Jacob, Sinha Meenal, McHenry Lauren K, Nasholm Nicole M, Chuntova Pavlina, Sundström Anders, Genoud Vassilis, Shahani Shilpa A, Wang Leo D, Brown Christine E, Walker Paul R, Swartling Fredrik J, Fong Lawrence, Okada Hideho, Weiss William A, Hellström Mats |
| 697893 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma |
2021-06-01 |
10.1136/jitc-2020-002057 |
Zakharia Yousef, McWilliams Robert R, Rixe Olivier, Drabick Joseph, Shaheen Montaser F, Grossmann Kenneth F, Kolhe Ravindra, Pacholczyk Rafal, Sadek Ramses, Tennant Lucinda L, Smith Christopher M, Kennedy Eugene P, Link Jr Charles J, Vahanian Nicholas N, Yu Jiayi, Shen Steven S, Brincks Erik L, Rossi Gabriela R, Munn David, Milhem Mohammed |
| 697892 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice |
2021-06-01 |
10.1136/jitc-2021-002715 |
Pieper Alexander A, Rakhmilevich Alexander L, Spiegelman Daniel V, Patel Ravi B, Birstler Jen, Jin Won Jong, Carlson Peter M, Charych Deborah H, Hank Jacquelyn A, Erbe Amy K, Overwijk Willem W, Morris Zachary S, Sondel Paul M |
| 697891 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling |
2021-06-01 |
10.1136/jitc-2021-002373 |
Varudkar Namita, Oyer Jeremiah L, Copik Alicja, Parks Griffith D |
| 697890 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma |
2021-06-01 |
10.1136/jitc-2020-002305 |
Deng Haijing, Kan Anna, Lyu Ning, He Meng, Huang Xin, Qiao Shuang, Li Shaolong, Lu Wenhua, Xie Qiankun, Chen Huiming, Lai Jinfa, Chen Qifeng, Jiang Xiongying, Liu Shousheng, Zhang Zhenfeng, Zhao Ming |
| 697889 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events |
2021-06-01 |
10.1136/jitc-2021-002435 |
Brahmer Julie R, Abu-Sbeih Hamzah, Ascierto Paolo Antonio, Brufsky Jill, Cappelli Laura C, Cortazar Frank B, Gerber David E, Hamad Lamya, Hansen Eric, Johnson Douglas B, Lacouture Mario E, Masters Gregory A, Naidoo Jarushka, Nanni Michele, Perales Miguel-Angel, Puzanov Igor, Santomasso Bianca D, Shanbhag Satish P, Sharma Rajeev, Skondra Dimitra, Sosman Jeffrey A, Turner Michelle, Ernstoff Marc S |
